OPC-12759 Ophthalmic Suspension

· Otsuka Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for OPC-12759 Ophthalmic Suspension, covering 2013-06-05 to 2014-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Exploratory Study of OPC-12759 Ophthalmic Suspension [Phase 2]